49th week of 2019 patent applcation highlights part 11 |
Patent application number | Title | Published |
20190365719 | COMBINATION TREATMENTS OF HSP90 INHIBITORS FOR ENHANCING TUMOR IMMUNOGENICITY AND METHODS OF USE THEREOF | 2019-12-05 |
20190365720 | Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions | 2019-12-05 |
20190365721 | AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS | 2019-12-05 |
20190365722 | COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG INFECTIONS | 2019-12-05 |
20190365723 | PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH | 2019-12-05 |
20190365724 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | 2019-12-05 |
20190365725 | THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF | 2019-12-05 |
20190365726 | Novel Spiro and Cyclic Bis-Benzylidene Proteasome Inhibitor for the Treatment of Cancer, Diabetes and Neurological Disorders | 2019-12-05 |
20190365727 | SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS | 2019-12-05 |
20190365728 | PHARMACEUTICAL COMPOSITION COMPRISING BETAHISTINE | 2019-12-05 |
20190365729 | FORMULATIONS OF TEGAVIVINT AND RELATED COMPOUNDS | 2019-12-05 |
20190365730 | ANAESTHETIC COMPOSITION COMPRISING ROPIVACAINE, PRILOCAINE AND LIDOCAINE | 2019-12-05 |
20190365731 | INHIBITORS OF NUCLEOTIDYL TRANSFERASES AND USES IN HERPES AND HEPATITIS VIRAL INFECTIONS THEREFOR | 2019-12-05 |
20190365732 | TOPICAL AMLODIPINE SALTS FOR THE TREATMENT OF ANORECTAL DISEASES | 2019-12-05 |
20190365733 | METHODS OF IMPROVING CELL-BASED THERAPY | 2019-12-05 |
20190365734 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | 2019-12-05 |
20190365735 | COMPOSITIONS AND METHODS FOR TREATING VARICOSE VEINS | 2019-12-05 |
20190365736 | ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS | 2019-12-05 |
20190365737 | PHARMACEUTICAL COMPOSITION | 2019-12-05 |
20190365738 | AMORPHOUS SOLID DISPERSION OF VALBENAZINE TOSYLATE AND PROCESS FOR PREPARATION THEREOF | 2019-12-05 |
20190365739 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE | 2019-12-05 |
20190365740 | PREVENTION AND/OR TREATMENT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY | 2019-12-05 |
20190365741 | COMBINATIONS OF THE CDK4/6 INHIBITOR LEE011 AND THE MEK1/2 INHIBITOR TRAMETINIB, OPTIONALLY FURTHER COMPRISING THE PI3K INHIBITOR BYL719 TO TREAT CANCER | 2019-12-05 |
20190365742 | AZOLE TREATMENT REGIMEN WITH REDUCED HEPATOTOXICITY | 2019-12-05 |
20190365743 | HEDGEHOG PATHWAY INHIBITION FOR TREATMENT OF HIGH-RISK BASAL CELL CARCINOMA OR HIGH-RISK BASAL CELL CARCINOMA NEVUS SYNDROME | 2019-12-05 |
20190365744 | IMPROVED MULTI TYROSINE KINASE INHIBITOR THERAPY | 2019-12-05 |
20190365745 | USE OF CHRONIC TREATMENT WITH ATR INHIBITORS TO SENSITIZE CANCER CELLS TO PARP INHIBITORS | 2019-12-05 |
20190365746 | DOSING SCHEDULE OF A WNT INHIBITOR AND AN ANTI-PD-1 ANTIBODY MOLECULE IN COMBINATION | 2019-12-05 |
20190365747 | BENZENESULFONAMIDE DERIVATIVES OF QUINOXALINE, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE IN METHODS FOR TREATING CANCER | 2019-12-05 |
20190365748 | INHIBITORS OF HEPATITIS C VIRUS | 2019-12-05 |
20190365749 | COMPOSITION FOR REDUCING NERVOUS SYSTEM INJURY AND METHOD OF MAKING AND USE THEREOF | 2019-12-05 |
20190365750 | METHOD OF REDUCING PULMONARY EXACERBATIONS IN RESPIRATORY DISEASE PATIENTS | 2019-12-05 |
20190365751 | IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-P- HTHALAZIN-1-ONE | 2019-12-05 |
20190365752 | QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | 2019-12-05 |
20190365753 | NEGATIVE ALLOSTERIC MODULATORS OF MGLUR5 FOR USE IN THE TREATMENT OF MATURE BRAIN DAMAGES | 2019-12-05 |
20190365754 | METHOD OF ELIMINATING STEM CELLS | 2019-12-05 |
20190365755 | 2-ANILINOPYRIMIDINE DERIVATIVES AS THERAPEUTIC AGENTS FOR TREATMENT OF BRAIN CANCERS | 2019-12-05 |
20190365756 | PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS | 2019-12-05 |
20190365757 | STABLE AND SOLUBLE FORMULATIONS OF RECEPTOR TYROSINE KINASE INHIBITORS, AND METHODS OF PREPARATION THEREOF | 2019-12-05 |
20190365758 | IDENTIFICATION OF AGENTS DISPLAYING FUNCTIONAL ACTIVATION OF DOPAMINE D2 AND D4 RECEPTORS | 2019-12-05 |
20190365759 | PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF | 2019-12-05 |
20190365760 | A THERAPEUTIC OR PROPHYLACTIC AGENT FOR ISCHEMIC DISEASE, GLAUCOMA, OPTIC NERVE DISEASE, RETINAL DEGENERATIVE DISEASE, ANGIOGENIC RETINAL DISEASE, CANCER, NEURODEGENERATIVE OR AUTOIMMUNE DISEASE, AND A HYPOXIA INDUCING FACTOR INHIBITOR | 2019-12-05 |
20190365761 | Liquid Nutritional Composition Containing 5-Methyltetrahydofolic Acid | 2019-12-05 |
20190365762 | MEDICINAL COMPOSITION INHIBITING NEOVASCULARIZATION PROLIFERATION FACTOR | 2019-12-05 |
20190365763 | SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | 2019-12-05 |
20190365764 | Dosing Regimen for the Treatment of PI3K Related Disorders | 2019-12-05 |
20190365765 | METHODS OF INHIBITING SERUM GLUCOCORTICOID INDUCED KINASE 1 (SGKI) AS A TREATMENT FOR SALT AND WATER BALANCE DISEASES | 2019-12-05 |
20190365766 | ANIMAL AND HUMAN ANTI-MALARIAL AGENTS | 2019-12-05 |
20190365767 | COMBINATIONS AND METHODS COMPRISING A CAPSID ASSEMBLY INHIBITOR | 2019-12-05 |
20190365768 | N-{[2-(PIPERIDIN-1-YL)PHENYL](PHENYL)METHYL}-2-(3-OXO-3,4-DIHYDRO-2H-1,4-B- ENZOXA ZIN-7-YL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ROR-GAMMA MODULATORS FOR TREATING AUTOIMMUNE DISEASES | 2019-12-05 |
20190365769 | COMPOSITIONS AND METHODS OF MODULATING SHIRT-CHAIN DEHYDROGENASE ACTIVITY | 2019-12-05 |
20190365770 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT | 2019-12-05 |
20190365771 | APILIMOD COMPOSITIONS AND METHODS FOR USING SAME IN THE TREATMENT OF ALZHEIMER'S DISEASE | 2019-12-05 |
20190365772 | SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDIN- E-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | 2019-12-05 |
20190365773 | SOLID DOSAGE FORM CONTAINING QUINAZOLINE DERIVATIVE | 2019-12-05 |
20190365774 | COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY | 2019-12-05 |
20190365775 | COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | 2019-12-05 |
20190365776 | THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE | 2019-12-05 |
20190365777 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | 2019-12-05 |
20190365778 | TREPROSTINIL ADMINISTRATION BY INHALATION | 2019-12-05 |
20190365779 | METHODS FOR DETECTING INTRACRANIAL NEOPLASMS | 2019-12-05 |
20190365780 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2019-12-05 |
20190365781 | METHODS AND COMPOSITIONS TARGETING GLUCOCORTICOID AND IL-27 SIGNALING FOR MODULATING IMMUNE RESPONSES | 2019-12-05 |
20190365782 | HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF | 2019-12-05 |
20190365783 | HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF | 2019-12-05 |
20190365784 | USE OF BRASSINOSTEROID ANALOGS FOR THE TREATMENT OF DERMAL DISORDERS BY SELECTIVELY MODULATING LIVER X RECEPTORS (LXR) AND DERMAL DISEASE TREATMENT BY BRASSINOSTEROID ANALOGS ACTING AS SELECTIVE LIVER X RECEPTOR (LXR) MODULATORS | 2019-12-05 |
20190365785 | INHIBITION OF UNFOLDED PROTEIN RESPONSE FOR SUPPRESSING OR PREVENTING ALLERGIC REACTION TO FOOD | 2019-12-05 |
20190365786 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES | 2019-12-05 |
20190365787 | ANTI-FATIGUE COMPOSITION | 2019-12-05 |
20190365788 | CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES | 2019-12-05 |
20190365789 | Specialized Tongue Spray Containing Gymnemic Acid And Exogenous Ketones | 2019-12-05 |
20190365790 | Compounds, Compositions and Methods for Prevention or Treatment of Liver and Lipid-related Conditions | 2019-12-05 |
20190365791 | SYNERGISTIC COMBINATION OF THERMOLYSIN AND AN ANTIBACTERIAL AGENT TO REDUCE OR ELIMINATE BACTERIAL BIOFILMS FROM SURFACES | 2019-12-05 |
20190365792 | Combination Therapy For Treating Cancer | 2019-12-05 |
20190365793 | CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES | 2019-12-05 |
20190365794 | METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE | 2019-12-05 |
20190365795 | OLIGONUCLEOTIDES FOR MODULATING ATXN2 EXPRESSION | 2019-12-05 |
20190365796 | CROSSLINKED CHONDROITIN SULFATE, COMPOSITION CONTAINING SAME, AND TREATMENT AGENT FOR EYE DISEASE | 2019-12-05 |
20190365797 | Systems and Methods for Delivery of Nitric Oxide | 2019-12-05 |
20190365798 | METHOD OF ADMINISTRATION AND TREATMENT | 2019-12-05 |
20190365799 | THERAPIES FOR THE TREATMENT OF LIDOCAINE-INEFFECTIVE AND HYPOKALEMIC CONDITIONS | 2019-12-05 |
20190365800 | EXTENDED USE ZIRCONIUM SILICATE COMPOSITIONS AND METHODS OF USE THEREOF | 2019-12-05 |
20190365801 | IRON OXIDE/NANOKAOLIN COMPOSITE HEMOSTATIC AGENT AND PREPARATION METHOD THEREOF | 2019-12-05 |
20190365802 | Oral Delivery Product | 2019-12-05 |
20190365803 | NANOSTRAWS METHODS AND APPARATUSES | 2019-12-05 |
20190365804 | COMPOSITION COMPRISING A SUBSTANTIALLY PURE POPULATION OF MULTIPOTENT STROMAL CELLS ENCAPSULATED IN PLATELET-POOR PLASMA (PPP) | 2019-12-05 |
20190365805 | CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | 2019-12-05 |
20190365806 | IMMUNOLOGICALLY DISCERNIBLE CELL SURFACE VARIANTS FOR USE IN CELL THERAPY | 2019-12-05 |
20190365807 | IMMUNE CELLS DEFECTIVE FOR SUV39H1 | 2019-12-05 |
20190365808 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2019-12-05 |
20190365809 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2019-12-05 |
20190365810 | Coordinating Gene Expression Using RNA Destabilizing Elements | 2019-12-05 |
20190365811 | FRACTAL COMBINATION THERAPY | 2019-12-05 |
20190365812 | NATURAL KILLER (NK) CELLS EXPRESSING AN ANTIGEN-SPECIFIC FUNCTIONAL T CELL RECEPTOR (TCR) COMPLEX, METHODS FOR PRODUCTION THEREOF, AND METHODS FOR THERAPEUTIC USE THEREOF | 2019-12-05 |
20190365813 | ANTI-CANCER T CELLS AND THEIR PREPARATION USING COENZYME A | 2019-12-05 |
20190365814 | VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME | 2019-12-05 |
20190365815 | NATURAL KILLER CELL EXPRESSING ANTI-COTININE CHIMERIC ANTIGEN RECEPTOR | 2019-12-05 |
20190365816 | GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBOIDES FOR THE TREATMENT OF CANCER | 2019-12-05 |
20190365817 | POINT-OF-CARE AND/OR PORTABLE PLATFORM FOR GENE THERAPY | 2019-12-05 |
20190365818 | GENETICALLY-TAGGED STEM CELL LINES AND METHODS OF USE | 2019-12-05 |